Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b

Fig. 1

Expression levels of HCG18 and miR-29a/b in patient tumour tissues and EOC cell lines. A The data about the correlation analysis of HCG18 levels and the survival of patients with EOC was downloaded from Kaplan Meier plotter. B HCG18 expression levels in EOC tissues (n = 30) and normal tissues (n = 30) as detected by qRT–PCR. C HCG18 expression levels in EOC cell lines and normal cell lines by qRT–PCR (n = 3). D–E Expression levels of miR-29a/b in EOC tissues (n = 30) and normal tissues (n = 30) was detected using qRT–PCR. F–G Expression levels of miR-29a/b in EOC cell lines and normal cell lines by qRT–PCR (n = 3). H–I The interaction of HCG18 and miR-29a/b was determined using sequence analysis and dual luciferase reporter assays (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page